Characterization of a New Human Cell Line (CH-3573) Derived from a Grade II Chondrosarcoma with Matrix Production

This publication has 35 references indexed in Scilit:

• Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down‐regulation and p16 overexpression inhibit cell growth in vitro
  Journal of Cellular and Molecular Medicine, 2009
• A novel mutated cell line with characteristics of dedifferentiated chondrosarcoma
  International Journal of Molecular Medicine, 2009
• Pathology of primary malignant bone and cartilage tumours
  International Orthopaedics, 2006
• Array‐comparative genomic hybridization of central chondrosarcoma
  Cancer, 2006
• Deregulation of the G1 to S-Phase Cell Cycle Checkpoint Is Involved in the Pathogenesis of Human Osteosarcoma
  Diagnostic Molecular Pathology, 2004
• Chromosome 9 Alterations and Trisomy 22 in Central Chondrosarcoma: A Cytogenetic and DNA Flow Cytometric Analysis of Chondrosarcoma Subtypes
  Diagnostic Molecular Pathology, 2001
• Changes inp14ARF do not play a primary role in human chondrosarcoma tissues
  International Journal of Cancer, 2001
• Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas
  Surgical Neurology, 1997
• Partial deletions of the CDKN2 and MTS2 putative tumor suppressor genes in a myxoid chondrosarcoma
  Cancer Letters, 1996
• Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan‐rich cartilage‐like nodules and to respond to insulin in vitro
  International Journal of Cancer, 1991